Skip to content

Arvinas ARVN Business Segments — Non program-specific external expense

Similar metrics at other companies

Sionna Therapeutics, Inc. Common Stock logo
SIONReportable Segment — External research and development expense
$12.93M+29.6%
Shattuck Labs, Inc. logo
STTKReportable Segment — Other expense
$778K+13.2%
CNB Financial logo
CCNEReportable Segment — Other non-interest expenses
$5.87M+24.7%
PCB Bancorp logo
PCBReportable Segment — Other expense
$2.82M-9.4%
Lexicon Pharmaceuticals logo
LXRXReportable Segment — Other segment expense
$3.08M+9.9%
Yext logo
YEXTReportable Segment — Other segment expenses
$22.14M+4.4%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept arvn:ResearchAndDevelopmentExpenseNonProgramSpecific.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's business segments — non program-specific external expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's business segments — non program-specific external expense?
Arvinas (ARVN) reported business segments — non program-specific external expense of $9.2M in Q1 2026.
How has Arvinas's business segments — non program-specific external expense changed year-over-year?
Arvinas's business segments — non program-specific external expense decreased by 33.8% year-over-year, from $13.9M to $9.2M.
What is the long-term trend for Arvinas's business segments — non program-specific external expense?
Over 3 years (2022 to 2025), Arvinas's business segments — non program-specific external expense has grown at a -8.7% compound annual growth rate (CAGR), from $64.3M to $49M.
What does business segments — non program-specific external expense mean?
These are external costs incurred by the segment that are not directly attributable to a specific research or development program. Monitoring these expenses helps assess the overhead and infrastructure costs required to support the broader research organization.